Vaxxinity Investor Relations Material
Latest events
Q4 2023
27 Mar, 2024
Corporate Presentation
12 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vaxxinity Inc
Access all reports
Vaxxinity Inc. is a biotechnology company focused on developing immunotherapies for chronic diseases and infectious conditions. The company specializes in vaccine-based treatments designed to harness the immune system for conditions such as neurodegenerative disorders, cardiovascular diseases, and viral infections. The company is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
VAXX
Country
🇺🇸 United States